Semin Reprod Med 2014; 32(03): 155-156
DOI: 10.1055/s-0034-1371085
Introduction to the Guest Editor
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Kathleen M. Hoeger, MD, MPH

Richard S. Legro
1   Department of Obstetrics and Gynecology, Penn State College of Medicine, Hershey, Pennsylvania
› Author Affiliations
Further Information

Publication History

Publication Date:
08 April 2014 (online)

Zoom Image

Our guest editor for this issue of the Seminars in Reproductive Medicine is Kathleen M. Hoeger, MD. Dr. Hoeger is a professor of Obstetrics and Gynecology at the University of Rochester School of Medicine and Dentistry and director of the Division of Reproductive Endocrinology, Department of Obstetrics and Gynecology. Dr. Hoeger is a proud graduate of many esteemed institutions of learning, beginning with the Palmyra High School in Palmyra, PA (∼5 miles as the crow flies from my window at work). She completed her undergraduate degree at the Stanford University, medical school at Jefferson Medical College, and stayed at Thomas Jefferson University Hospital for her residency in obstetrics and gynecology, and fellowship in reproductive endocrinology at the University of Virginia. She continued her career development after joining faculty at the University of Rochester by obtaining a Masters of Public Health as well as being selected as a scholar for the Women's Reproductive Health Research Career Development Program Scholar at the University of Rochester.

Dr. Hoeger has had a longstanding clinical and research interest in polycystic ovary syndrome (PCOS). She has especially been interested in the treatment of adolescents with PCOS and has studied extensively the role of lifestyle modification with and without adjuvant therapies such as metformin and oral contraceptives for which she received several National Institutes of Health (NIH) grants to support her work. She has been recognized for her research with several prominent lectureships and participation on multiple expert panels including NIH study sections, the Endocrine Society Clinical Practice Guidelines for PCOS, and as a member of the Special Advisory Committee for Reproductive Health Drugs at the Food and Drug Administration.

She is especially well connected with researchers within the field and has assembled an outstanding and eclectic group of authors to explore developmental origins of PCOS. I congratulate her for her efforts.